Literature DB >> 1763481

Evaluation of a beef-based chewable formulation of pyrantel pamoate against induced and natural infections of hookworms and ascarids in dogs.

J N Clark1, C P Daurio, D W Barth, A F Batty.   

Abstract

Pyrantel pamoate, formulated in a beef-based chewable tablet, was evaluated for efficacy in dogs against induced and natural infections of Toxocara canis, Toxascaris leonina, Ancylostoma caninum and Uncinaria stenocephala. Dose titration trials were conducted in Canada, the UK and Germany in dogs treated with pyrantel (as pamoate salt) at 0, 2.5, 5 or 10 mg kg-1 body weight. These studies showed that a dose rate of 2.5 mg kg-1, the efficacy of pyrantel against adult T. canis, T. leonina, U. stenocephala and A. caninum was 76.1, 85.6, 100 and 87.9%, respectively. Efficacy at 5 mg kg-1 against the same parasites was 94.2, 92.0, 93.5 and 93.8%, respectively, and at 10 mg kg-1 efficacy was 91.2, 97.6, 98.7 and 91.3%, respectively. No adverse effects due to treatment were seen in any of these trials.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763481     DOI: 10.1016/0304-4017(91)90089-e

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Efficacy of eprinomectin against Toxacara canis in dogs.

Authors:  Esma Kozan; Feride Kircali Sevimli; Fatih Mehmet Birdane; Ramazan Adanir
Journal:  Parasitol Res       Date:  2007-11-10       Impact factor: 2.289

2.  Effects of pyrantel pamoate on adult and preadult Toxocara canis worms: an electron microscope and autoradiography study.

Authors:  U Mackenstedt; S Schmidt; H Mehlhorn; M Stoye; W Traeder
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 3.  Review on Selected Aggression Causes and the Role of Neurocognitive Science in the Diagnosis.

Authors:  Aleksandra Kleszcz; Paulina Cholewińska; Greta Front; Jakub Pacoń; Robert Bodkowski; Marzena Janczak; Tadeusz Dorobisz
Journal:  Animals (Basel)       Date:  2022-01-24       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.